Ignite Creation Date:
2024-05-06 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 12:49 PM
Study NCT ID:
NCT03589222
Status:
UNKNOWN
Last Update Posted:
2021-02-04
First Post:
2018-06-12
Brief Title:
SELIBORDARA Selinexor Bortezomib and Daratumumab in Multiple Myeloma
Sponsor:
PETHEMA Foundation
Organization:
PETHEMA Foundation
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory Multiple Myeloma |
Keywords: